Back to discover
Disease
Leukopenia
Late-stage therapeutic developmentEmerging research
2
Publications
5
Clinical trials
2005
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
A Phase I Study of MozobilTM in the Treatment of Patients With WHIMS
Clinical trial2026-09-09Status changed to Completed · ClinicalTrials.gov
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 1 clinical trial expected to report results, the earliest in Q1 2027.
Upcoming Milestones
Major developments
Upcoming trial readoutImportant
Results expected Q1 20272026-03-24
Clinical milestoneWorth watching
Completed2026-08-06
Clinical MilestonesViewHide
Results expected
- 2026-03-24Efficacy of Luspatercept In Clonal Cytopenias of Uncertain SignificanceResults expected Q1 2027
Recently completed
- 2026-08-06A Phase I Study of MozobilTM in the Treatment of Patients With WHIMSCompleted
Activity timeline2
- 2026-08-06ClinicalA Phase I Study of MozobilTM in the Treatment of Patients With WHIMSCompleted
- 2026-03-24ClinicalEfficacy of Luspatercept In Clonal Cytopenias of Uncertain SignificanceResults expected Q1 2027
Clinical trials
The current development programme across all trial phases.
Clinical programme
5
1
2
4
Late-stage studies
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
Most influential
Recent publications
Major themes3
- Leukocyte Count1
- Leukopenia1
- Lymphocytes1
Leading journals2
- Annals of internal medicine1
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
Leading researchers8
- Antón A1
- Bodey GP1
- Buckley M1
- Chan S1
- Cognetti F1
- Conte P1
- Extra JM1
- Freireich EJ1
Affiliations (unnormalised)1
- Institut Gustave-Roussy1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.